Park K S, Rifat S, Eck H, Adachi K, Surrey S, Poncz M
Division of Hematology, Children's Hospital of Philadelphia, PA 19104.
Blood. 1990 Mar 15;75(6):1290-5.
Platelet factor 4 (PF4) is a 70 amino acid protein released from the alpha-granules of platelets after activation. The exact biologic function of this protein is unknown. We have constructed an expression vector for recombinant PF4 (rPF4) in the T7-based promoter vector pT7-7 to better study the relationship between PF4 structure and function. The protein was expressed in Escherichia coli and purified to homogeneity by heparin-agarose affinity chromatography and reverse-phase high-performance liquid chromatography. Purity of protein was confirmed by immunoblot analysis and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, which resulted in a single component with a molecular weight of 8,000 daltons. The amino acid composition and sequence of the N-terminal 20 residues showed that rPF4 is identical to PF4 prepared from human platelets (hPF4), except for an N-terminal initiating methionine residue. Immunoblots revealed that rPF4 and hPF4 bound polyclonal anti-hPF4 equally well, while chemotaxis experiments demonstrated similar potencies as neutrophil attractants. Dose-dependent neutrophil chemotactic responses and competitive studies with polyclonal anti-hPF4 antiserum further demonstrate similar chemotactic properties of the two PF4 species. In conclusion, our data show that this recombinant protein and the native protein appears to have similar immunologic, heparin-binding, and chemotactic properties. The chemotactic properties of hPF4 appear to be entirely intrinsic to the protein and not due, in part, to any contaminating protein. Furthermore, our expression vector should prove useful for the construction of recombinant forms of PF4 to investigate structure/function relationships of this biologically important protein.
血小板因子4(PF4)是一种由70个氨基酸组成的蛋白质,在血小板激活后从α-颗粒中释放出来。该蛋白质的确切生物学功能尚不清楚。我们构建了一种基于T7启动子载体pT7-7的重组PF4(rPF4)表达载体,以更好地研究PF4结构与功能之间的关系。该蛋白在大肠杆菌中表达,并通过肝素-琼脂糖亲和色谱和反相高效液相色谱纯化至同质。通过免疫印迹分析和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳确认了蛋白质的纯度,结果显示为单一成分,分子量为8000道尔顿。N端20个残基的氨基酸组成和序列表明,rPF4与人血小板制备的PF4(hPF4)相同,只是N端起始甲硫氨酸残基不同。免疫印迹显示,rPF4和hPF4与多克隆抗hPF4的结合效果相同,而趋化实验表明它们作为中性粒细胞趋化剂的效力相似。剂量依赖性中性粒细胞趋化反应以及与多克隆抗hPF4抗血清的竞争性研究进一步证明了两种PF4的趋化特性相似。总之,我们的数据表明,这种重组蛋白和天然蛋白似乎具有相似的免疫、肝素结合和趋化特性。hPF4的趋化特性似乎完全是该蛋白固有的,而不是部分归因于任何污染蛋白。此外,我们的表达载体应该对构建PF4的重组形式以研究这种生物学重要蛋白的结构/功能关系有用。